Sanofi and GSK begin clinical trials of coronavirus vaccine
pharmaphorum
SEPTEMBER 4, 2020
Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine, as AstraZeneca expanded studies of its rival into Japan. Sanofi is leading the clinical development and registration of the COVID-19 vaccine. The post Sanofi and GSK begin clinical trials of coronavirus vaccine appeared first on.
Let's personalize your content